Abstract
Immunotherapeutic drugs, such as immune checkpoint inhibitors (ICIs), have revolutionized cancer treatment, significantly increasing patient survival. These drugs stimulate defense cells to fight the tumor and can promote long-lasting effects, possibly by inducing immunological memory in patients (Rui et al., 2023). However, many aspects are still unknown and represent challenges for the …